Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Traditional drug development relies on costly trial-and-error methods.
• Drug design, particularly modifying existing compounds, can minimize risks and costs.
• Hydroxyurea derivatives show promise as anticancer agents, but require optimization.

Purpose of the Study:

• To synthesize novel 1-(benzoyloxy)urea derivatives.
• To evaluate the anticancer activity of these derivatives.
• To establish a Quantitative Structure-Activity Relationship (QSAR) model for predicting cytotoxic activity.

Main Methods:

• Synthesis of 1-(benzoyloxy)urea derivatives using a modified Schotten-Baumann method.
• Characterization of synthesized compounds using UV, IR, NMR, and Mass Spectrometry.
• In vitro anticancer activity assessment using the MTT assay on HeLa cells.
• QSAR analysis using SPSS to correlate physicochemical properties with cytotoxic activity (log(1/IC50)).

Main Results:

• Successful synthesis and characterization of 1-(benzoyloxy)urea derivatives with enhanced lipophilic, electronic, and steric properties.
• Demonstrated cytotoxic activity against HeLa cancer cells.
• Developed a QSAR model: Log 1/IC50 = -0.205(σ) - 0.051(Es) - 1.911, identifying key structural descriptors.

Conclusions:

• The synthesized 1-(benzoyloxy)urea derivatives exhibit significant anticancer potential.
• QSAR analysis provides a valuable tool for predicting and optimizing the cytotoxic activity of these compounds.
• This study contributes to the rational design of novel anticancer agents.